TEL:020-31701980      FAX:020-31701979     E-mail:sales@mx008.com
China Mingxuan
Service Hotline:020-3171980
搜索

News
MX trends
industry trends
fair information
 
Micro-channel
 
Information details You are here:Home >> News >> industry trends
 
Medtronic throw the surgery robot company to fire!
 
Author:中国铭铉 企划部  Release Time:2017-4-7 10:14:50  Number Browse:468
 
Medical network - April 6, spinal surgery is becoming more and more attention, this is because, the number of surgeons can't satisfy the need for surgery, patients with, therefore, surgical robots are becoming the popular investment hot spots. 
 
To see Mazor Robotics (matsu) company. 
 
Recently, the focus of spinal surgery robot company, on March 17, announced a partnership with medtronic, cooperation to promote their own Mazor X surgical robot. Mazor X is to simplify the guidance of the spinal surgery system, designed to help surgeons better complete the risky surgery. 
 
In the orthopaedic surgery market, Mazor gaining favor X platform. 
 
(Marzor X system. The company's web site) 
 
As is known to all, medtronic is for medical devices industry giants, the agreement on joint promotion was optimistic about the investment community and considered to be the favour of the market of the surgical robot, good for Mazor market development. 
 
According to the Motley Fool, this cooperation signed in early 2016, at the time you took a fancy to Mazor potential medtronic, spent money, decided to Mazor robotics companies invest 20 million dollar, involvement in equity investment way. 
 
In medtronic after has initially invested $11.9 million, and a significant investment. Ready to go into to the medical equipment giant obtained Mazor company 7.27% stake. 
 
Since signed a cooperation agreement, Mazor and medtronic began to actively promote Mazor products in the market, as well as Mazor X the commercialization of the surgical robot joint marketing, promotion and training. 
 
In the fourth quarter, the company has received the 21 Mazor X system orders. 
 
As of February 31, Mazor income grew by 59% in the fourth quarter, to $14 million. And the same period of last year to $8.8 million. Income rose by 88% in the us market, at $12.6 million, and $6.7 million over the same period last year. 
 
At the same time, the company confirmed that 13 Mazor X orders and two Renaissance surgery surgical robot system sales. 
 
A medtronic MDT channels, is expected to strengthen. The two resources, including hundreds of experienced clinical experts can help improve brand awareness and speed up the commercialization process. 
 
Reflected in stock prices, the company has been rising in value. In the latest quarter, the performance is outstanding, not only leading the market, and lead the whole medical equipment sector, the charm of the surgical robot. 
 
 
 
Demand in the domestic, orthopaedic surgery is growing rapidly. This is because, as the population ages, people suffering from spinal stenosis, lumbar dish outstanding probability on the rise, such as the direct and effective surgery is deal with the pain treatment. 
 
Previous article:Administration of 2017, 6 national medical instrument quality announcement
Next article:Beijing medicine apart will implement big hospital drugs also can buy in the community
 
Log in  Website Map All right reserved by China Mingxuan, Guangzhou ICP #16026227
    

粤公网安备 44011202000029号